VITRUVIAS THERAPEUTICS INC recalls
2 notices naming VITRUVIAS THERAPEUTICS INC as the recalling firm, since August 21, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
Hazard (FDA): Potential for the Product to be Superpotent
FDAMedicines